drugset / Trial / NCT00951041
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the study is to evaluate the safety and immunogenicity of GSK Biologicals' influenza vaccine GSK2340272A.
Timeline
- Start
- 2009-08-11
- Primary completion
- 2010-08-30
- Completion
- 2010-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK2340269A | Vaccine | — | Intramuscular |
| Subject | GSK2340272A | Vaccine | — | Intramuscular |